The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Hepatitis B Surface Antibody Quantitative
Also known as: MMR IgG Panel Measles Mumps Rubella
Also known as: Chicken Pox, Herpes Zoster, Shingles, VaricellaZoster Virus Antibody IgG
The Immunity Panel panel contains 3 tests with 5 biomarkers.
Brief Description: The Immunity Panel is a set of laboratory tests designed to assess an individual's immunity status against specific infectious diseases. By measuring the presence and levels of specific antibodies in the blood, the panel provides valuable insights into whether an individual has been previously exposed to these pathogens or has been vaccinated against them, thus offering protection.
Please Note: Varicella-Zoster Virus Antibody IgG #4439 reliably measures immunity due to previous infection but may not be sensitive enough to detect antibodies induced by vaccination. Thus, a negative result in a vaccinated individual does not necessarily indicate susceptibility to VZV infection. A more sensitive test for vaccination-induced immunity is Varicella Zoster Virus Antibody Immunity Screen, ACIF #14505.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
The Immunity Panel may be ordered:
Pre-Employment or School Entry: Many healthcare settings, educational institutions, and other environments where the risk of disease transmission is higher require proof of immunity against certain diseases.
After Vaccination: To confirm that the vaccine has elicited a sufficient immune response, especially in individuals with known immune system issues.
Post-Infection: After a suspected or confirmed infection, to check if it has resulted in the development of immunity.
Pre-Travel: Before traveling to areas where these diseases are more prevalent, to ensure adequate protection.
Immune Status Check: In individuals with unknown vaccination histories or those who are unsure of their past disease exposures.
Hepatitis B Surface Antibody Quantitative: Measures the amount of antibody against the hepatitis B virus, indicating immunity either from past infection or vaccination.
Measles IgG Antibody: Determines immunity to measles, either from past infection or vaccination.
Mumps Virus IgG Antibody: Assesses immunity to mumps, resulting from past infection or vaccination.
Rubella IgG Antibody: Indicates immunity to rubella, often a result of either past infection or receiving the MMR vaccine.
Varicella-Zoster Virus IgG Antibody: Confirms immunity to chickenpox (and indirectly shingles), arising from infection, or vaccination in the case of positive results.
Hepatitis B: A viral infection that affects the liver and can lead to chronic disease and liver cancer. Immunity suggests protection against this virus.
Measles: A highly contagious viral disease with symptoms like rash and fever. Immunity provides protection against this disease.
Mumps: Another contagious virus causing swelling of salivary glands. Immunity indicates protection.
Rubella (German Measles): A viral disease that can cause birth defects if a pregnant woman contracts it. Immunity offers protection against these complications.
Varicella-Zoster (Chickenpox): A contagious virus causing an itchy rash and flu-like symptoms. Immunity signifies protection against this infection and a decreased risk of shingles later in life.
In conclusion, the Immunity Panel offers critical information regarding an individual's protection against specific infectious diseases. Whether ensuring vaccine efficacy, confirming post-infection immunity, or meeting institutional or travel requirements, understanding one's immunity status is pivotal in preventing disease spread and safeguarding public health.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.